{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:06:03Z","timestamp":1759017963504,"version":"3.44.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.annder.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T07:41:29Z","timestamp":1629963689000},"page":"272-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intralesional rituximab treatment for atypical refractory granuloma faciale"],"prefix":"10.1016","volume":"148","author":[{"given":"E.","family":"Joly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Duval-Modeste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Arhant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Comoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dompmartin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2021.06.001_bib0050","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jaad.2005.08.021","article-title":"Granuloma faciale: a clinicopathologic study of 66 patients","volume":"53","author":"Ortonne","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.06.001_bib0055","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1590\/abd1806-4841.20164628","article-title":"Granuloma faciale: clinical, morphological and immunohistochemical aspects in a series of 10 patients","volume":"91","author":"Oliveira","year":"2016","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.annder.2021.06.001_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2340\/00015555-2784","article-title":"Granuloma faciale treatment: a systematic review","volume":"98","author":"Lindhaus","year":"2018","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.annder.2021.06.001_bib0065","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jamadermatol.2018.2681","article-title":"Assessment of treatment of refractory granuloma faciale with intralesional rituximab","volume":"154","author":"Morgado-Carrasco","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2021.06.001_bib0070","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annder.2021.06.001_bib0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00000372-200210000-00013","article-title":"Granuloma faciale: a diagnosis deserving of dignity","volume":"24","author":"LeBoit","year":"2002","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.annder.2021.06.001_bib0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaad.2003.11.071","article-title":"Granuloma faciale: a clinicopathological study of 11 cases","volume":"51","author":"Marcoval","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.06.001_bib0085","first-page":"19","article-title":"Diagnosis and treatment of IgG4-related disease","volume":"401","author":"Kamisawa","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.annder.2021.06.001_bib0090","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/archderm.142.11.1407","article-title":"Successful use of rituximab for cutaneous vasculitis","volume":"142","author":"Chung","year":"2006","journal-title":"Arch Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:10:15Z","timestamp":1758971415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963821000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0151963821000648"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2021.06.001","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intralesional rituximab treatment for atypical refractory granuloma faciale","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}